The Physician Payments Sunshine Act and the Future of Healthcare Transparency: Part 1

February 2, 2022

By: Mary Kate McDevitt , Marc Stephen Raspanti

Part 2 of this article series will be published in the March 2022 issue of Compliance Today and focus on examples of enforcement actions and examine the future of transparency statutes.

The Physician Payments Sunshine Act (PPSA) took effect in 2013.[1] It requires medical product manufacturers to disclose to the Centers for Medicare & Medicaid Services (CMS) payments or transfers of value made to physicians or teaching hospitals. The act also requires manufacturers and group purchasing organizations to disclose any physician’s ownership or financial interest in those companies. The disclosed data is published annually in a publicly searchable database.[2] The rationale behind the public availability of the data is to empower patients through transparency to mitigate the putative effect of financial incentives on clinical behavior and the public and prevent physician-industry conflicts of interest.

This two-part article provides a comprehensive analysis of the major healthcare regulatory enforcement statutes and their continuingly expansive use. First, we’ll reference the issues in the healthcare industry that led to the enactment of the PPSA that are relevant to an understanding of the current law and its growing enforcement. Next, we’ll discuss key statutory language and PPSA’s evolution. Then, we’ll consider the impact from a fraud and abuse standpoint, which is important to appreciate the significance of the first examples of Department of Justice enforcement of the act that follow, as well as the likely increase of private PPSA enforcement. We’ll also highlight other sunshine acts, including state and international ones. Finally, we’ll examine the future of transparency statutes, including the Hospital Price Transparency regulation,[3] the newest major transparency statute proposed; the Prescription Drug Price Transparency Act; and the Transparency in Coverage statute, which support the notion that transparency is a trend in the healthcare industry that will withstand the test of time.

The lead-up to the enactment of the Physician Sunshine Act

The Physician Payments Sunshine Act and its basic requirements

About the Authors

Mary Kate McDevitt ( is an associate in the Qui Tam/False Claims Act practice group of Pietragallo Gordon Alfano Bosick and Raspanti LLP in Philadelphia. Marc S. Raspanti ( is a name partner of Pietragallo Gordon Alfano Bosick & Raspanti LLP in Philadelphia.

Copyright 2022 Compliance Today, a publication of the Health Care Compliance Association (HCCA)

News & Events

Related News

24 Pietragallo Lawyers Named in 2022 Pennsylvania and Florida Super Lawyers and Rising Stars
May 23, 2022
Pietragallo is pleased to announce that 24 lawyers have been named as 2022 Super Lawyers and Rising Stars, including partner Marc Raspanti who was recognized in the Top 100 in Pennsylvania and Philadelphia. Read More
Pietragallo Law Firm Contributes to $24.5 Million Recovery as Multi-State Pain and Surgery Practice and Key Executives Settle False Claims Act Suits
April 12, 2022
TUESDAY, APRIL 12, 2022 – The United States Attorney’s Office for the Middle District of Florida and the Department of Justice announced today the settlement of four qui tam cases filed in Tampa.  Read More

Upcoming Events

Pamela Coyle Brecht to present at Federal Bar Association’s Qui Tam Section Roundtable
June 8, 2022
Pietragallo partner Pamela Coyle Brecht will be presenting virtually on “She Persisted: How Women Have Shaped False Claims Act Law” at the Federal Bar Association’s (FBA) 2022 Qui Tam Section Roundtable Discussion. Read More
Jeremy Abay to present at Seton Hall University School of Law
June 14, 2022
Jeremy Abay will present “The False Claims Act and Dealing with Whistleblowers” at Seton Hall University School of Law on Tuesday, June 14, 2022. Read More
View More News & Events